Fingerprint The fingerprint is based on mining the text of the scientific documents related to the associated persons. Based on that an index of weighted terms is created, which defines the key subjects of research unit

Gallbladder Neoplasms Medicine & Life Sciences
Gallbladder Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Carcinoma Medicine & Life Sciences
Chile Medicine & Life Sciences
Stomach Neoplasms Medicine & Life Sciences
Non-Small Cell Lung Carcinoma Medicine & Life Sciences
Cholecystectomy Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1984 2018

2 Citations

A dormant TIL phenotype defines non-small cell lung carcinomas sensitive to immune checkpoint blockers

Gettinger, S. N., Choi, J., Mani, N., Sanmamed, M. F., Datar, I., Sowell, R., Du, V. Y., Kaftan, E., Goldberg, S., Dong, W., Zelterman, D., Politi, K., Kavathas, P., Kaech, S., Yu, X., Zhao, H., Schlessinger, J., Lifton, R., Rimm, D. L., Chen, L. & 2 othersHerbst, R. S. & Schalper, K., Dec 1 2018, In : Nature communications. 9, 1, 3196.

Research output: Contribution to journalArticle

Tumor-Infiltrating Lymphocytes
phenotype
Lymphocytes
lymphocytes
Non-Small Cell Lung Carcinoma
2 Citations

Clinical Features and Management of Acquired Resistance to PD-1 Axis Inhibitors in 26 Patients With Advanced Non–Small Cell Lung Cancer

Gettinger, S. N., Wurtz, A., Goldberg, S. B., Rimm, D., Schalper, K., Kaech, S., Kavathas, P., Chiang, A., Lilenbaum, R., Zelterman, D., Politi, K. & Herbst, R. S., Jun 1 2018, In : Journal of Thoracic Oncology. 13, 6, p. 831-839 9 p.

Research output: Contribution to journalArticle

Non-Small Cell Lung Carcinoma
Holidays
Therapeutics
Lymph Nodes
Survival Rate

Immune Marker Profiling and Programmed Death Ligand 1 Expression Across NSCLC Mutations

Toki, M. I., Mani, N., Smithy, J. W., Liu, Y., Altan, M., Wasserman, B., Tuktamyshov, R., Schalper, K., Syrigos, K. N. & Rimm, D. L., Dec 1 2018, In : Journal of Thoracic Oncology. 13, 12, p. 1884-1896 13 p.

Research output: Contribution to journalArticle

Biomarkers
Ligands
Mutation
Tumor-Infiltrating Lymphocytes
Lymphocyte Activation